Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
YY Group Holding | YYGH | Nov 22, 2024 | 1.98 | +2.86 |
Zai Lab ADR | ZLAB | Nov 22, 2024 | 26.43 | +2.84 |
Zapp Electric Vehicles Group | ZAPP | Nov 22, 2024 | 1.88 | -3.09 |
ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B | AMND | Nov 22, 2024 | 55.59 | +0.43 |
ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B | AMTR | Nov 22, 2024 | 80.83 | +0.05 |
Zebra Technologies A | ZBRA | Nov 22, 2024 | 397.19 | +1.24 |
Zedge B | ZDGE | Nov 22, 2024 | 2.58 | +1.18 |
ZEEKR Intelligent Technology Holding | ZK | Nov 22, 2024 | 22.40 | +1.36 |
ZenaTech | ZENA | Nov 22, 2024 | 1.79 | 0.00 |
Zentalis Pharmaceuticals | ZNTL | Nov 22, 2024 | 3.23 | +1.57 |
Zentek | ZTEK | Nov 22, 2024 | 1.15 | +1.32 |
Zenvia A | ZENV | Nov 22, 2024 | 1.40 | +2.94 |
Zeo Energy A | ZEO | Nov 22, 2024 | 1.31 | -1.50 |
Zepp Health ADR | ZEPP | Nov 22, 2024 | 2.48 | -0.80 |
Zeta Global A | ZETA | Nov 22, 2024 | 22.38 | +3.04 |
Zevia A | ZVIA | Nov 22, 2024 | 2.19 | +6.83 |
Zevra Therapeutics | ZVRA | Nov 22, 2024 | 9.59 | +4.98 |
Zhibao Technology | ZBAO | Nov 22, 2024 | 3.00 | +12.36 |
Zhihu A ADR | ZH | Nov 22, 2024 | 3.60 | +0.84 |
Zhongchao A | ZCMD | Nov 22, 2024 | 1.06 | 0.00 |
Ziff Davis | ZD | Nov 22, 2024 | 58.24 | +1.78 |
Zillow Group A | ZG | Nov 22, 2024 | 80.79 | +1.93 |
Zillow Group C Capital Stock | Z | Nov 22, 2024 | 83.77 | +1.97 |
ZIM | ZIM | Nov 22, 2024 | 23.78 | -1.86 |
Zimmer Biomet | ZBH | Nov 22, 2024 | 110.22 | +1.68 |
ZimVie | ZIMV | Nov 22, 2024 | 14.17 | +3.13 |
Zions Bank | ZION | Nov 22, 2024 | 60.58 | +2.43 |
Zions Bank A Pref | ZIONP | Nov 22, 2024 | 23.59 | +0.37 |
Zions Bank G Pref | ZIONO | Nov 22, 2024 | 25.51 | +0.04 |
ZipRecruiter A | ZIP | Nov 22, 2024 | 9.09 | -0.66 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.